未登录.png)
分享.png)
收藏分享 收藏 分享 收藏 分享 收藏 分享 收藏 Gilteritinib versus salvage chemotherapy in predominantly Asian patients with relapsed/refractory FLT3-mutated acute myeloid leukemia: a regional analysis of COMMODORE in China, South-East Asia, and Russia
Jiang, Bin; Li, Jian; Liu, Ligen; Du, Xin; Jiang, Hao; Hu, Jianda; Zeng, Xiaoxi; Sakatani, Taishi; Kosako, Masanori; Deng, Yaru; Girshova, Larisa; Bondarenko, Sergey; Lee, Lily Wong Lee; Khuhapinant, Archrob; Martynova, Elena; Hasabou, Nahla; Wang, Jianxiang 分享 收藏 Azacitidine, Venetoclax Combined with Chidamide (ABC-14 Regimen) As an Induction Therapy for Newly Diagnosed AML: A Real-World Retrospective Analysis By the ABC-14 Collaboration Group阿扎胞苷、维奈克拉联合氯米芬（ABC-14方案）作为新诊断AML的诱导治疗：一项由ABC-14协作组进行的真实世界回顾性分析Weng, Jianyu; Deng, Chengxin; Huang, Zhenqian; Zhang, Yuming; Ying, Wang; Li, Minming; Wu, Ping; He, Honghua; Ye, Xu; Jiang, Yirong; Dong, Min; Liu, Zhenfang; Li, Xiaoliang; Zheng, Runhui; Zou, Maoquan; Lin, Lie; Zhao, Ying; Zhang, Xiangzhong; Cheng, Shuqin; Guo, Ziwen; Jiang, Xuejie; Li, Zhilun; Tan, Jiaqi; Luo, Chengwei Luo; Wu, Suijing; Lai, Peilong; Li, Yangqiu; Huang, Xin; Du, Xin 分享 收藏 Olverembatinib-Therapy in Patients with Accelerated-Phase Chronic Myeloid Leukaemia: A Multi-Centre Retrospective Study from China奥维雷巴替尼疗法在加速期慢性髓系白血病患者中的应用：一项来自中国的多中心回顾性研究Yuan, Mengyao; Zhou, Li; Du, Xin; Weng, Jianyu; Yang, Linhua; Ma, Yanping; Zhao, Shasha; Liu, Zhenfang; Wen, Qin; Bai, Qingxian; Feng, Xianqi; Han, Yanqiu; Li, Aifang; Liu, Chunshui; Leng, Qing; Meng, Li; Wang, Baohong; Ran, Xuehong; Wang, Xiaodong; Zhang, Haiguo; Zeng, Yun; Zhang, Yanli; Jiang, Qian 分享 收藏 Isatuximab Plus Bortezomib, Lenalidomide, and Dexamethasone (Isa-VRd) Versus Vrd in Chinese Patients with Newly Diagnosed Multiple Myeloma Who Are Ineligible for Transplant: IMROZ Subgroup AnalysisIsatuximab 联合硼替佐米、来那度胺和地塞米松（Isa-VRd）与 VRd 方案对比，适用于不适合移植的中国新诊断多发性骨髓瘤患者的 IMROZ 亚组分析An, Gang; Liu, Zhuogang; Jin, Jie; Cai, Zhen; Li, Wei; Xia, Zhongjun; Cen, Xinan; Hu, Yu; Mi, Jian-Qing; Jing, Hongmei; Zhan, Rong; Qu, Xiaoyan; Du, Xin; Gao, Dan; Zhao, Liang; Qiu, Lugui 分享 收藏 分享 收藏 Phase 3 study of gilteritinib versus salvage chemotherapy in predominantly Asian patients with relapsed/refractory FLT3-mutated acute myeloid leukemiaWang, Jianxiang; Jiang, Bin; Li, Jian; Liu, Ligen; Du, Xin; Jiang, Hao; Hu, Jianda; Yuan, Menghe; Sakatani, Taishi; Kadokura, Takeshi; Takeuchi, Masato; Kosako, Masanori; Ma, Xiao; Girshova, Larisa; Tan, Jerome; Bondarenko, Sergey; Lee, Lily Wong Lee; Khuhapinant, Archrob; Martynova, Elena; Hasabou, Nahla 分享 收藏 Long-term outcomes with HLX01 (HanliKang®), a rituximab biosimilar, in previously untreated patients with diffuse large B-cell lymphoma: 5-year follow-up results of the phase 3 HLX01-NHL03 studyQin, Yan; Song, Yongping; Wang, Dong; Bai, Ou; Feng, Jifeng; Sun, Xiuhua; Qiu, Lihua; Yang, Jianmin; Yang, Yu; Wang, Zhao; Hu, Jianda; Wang, Huaqing; Su, Hang; Jin, Zhengming; Qian, Wenbin; Jin, Chuan; Zhang, Mingzhi; Yu, Ding; Liu, Li; Chen, Guoan; Li, Yarong; Sun, Tao; Jin, Jie; Bao, Huizheng; Du, Xin; Zhou, Hui; Fu, Gan; Shi, Yuankai 分享 收藏 分享 收藏 Mesenchymal stem cells reversibly de-differentiate myofibroblasts to fibroblast-like cells by inhibiting the TGF-β-SMAD2/3 pathwayXu, Ruohao; Wu, Miao; Wang, Yawen; Li, Chao; Zeng, Lingji; Wang, Yulian; Xiao, Maozhi; Chen, Xiaomei; Geng, Suxia; Lai, Peilong; Du, Xin; Weng, Jianyu 分享 收藏 分享 收藏 分享 收藏 C3aR costimulation enhances the antitumor efficacy of CAR-T cell therapy through Th17 expansion and memory T cell inductionLai, Peilong; Chen, Xiaomei; Wang, Yulian; Wang, Jinghua; Zhang, Yuchen; Geng, Suxia; Li, Peng; Du, Xin; Weng, Jianyu; Pei, Duanqing 分享 收藏 Loss of miR-31-5p drives hematopoietic stem cell malignant transformation and restoration eliminates leukemia stem cells in miceZhu, Biying; Zhong, Wenbin; Cao, Xiuye; Pan, Guoping; Xu, Mengyang; Zheng, Jie; Chen, Huanzhao; Feng, Xiaoqin; Luo, Chengwei; Lu, Chen; Xiao, Jie; Lin, Weize; Lai, Chaofeng; Li, Mingchuan; Du, Xin; Yi, Qing; Yan, Daoguang 分享 收藏 Lower BCL11B expression is associated with adverse clinical outcome for patients with myelodysplastic syndrome较低的BCL11B表达与骨髓增生异常综合征患者的不良临床结局相关Huang, Xin; Chen, Cunte; Zhong, Mengjun; Geng, Suxia; Zhao, Yujie; Li, Minming; Deng, Chenxin; Zeng, Lingji; Wu, Ping; Lu, Zesheng; Weng, Jianyu; Du, Xin; Li, Yangqiu 分享 收藏 Decitabine With or Without Micro-Transplantation for the Treatment of Intermediate or High-Risk Myelodysplastic Syndrome: A Chinese Single-Center Retrospective Study of 22 PatientsLi, MinMing; Li, Chao; Geng, SuXia; Chen, XiaoMei; Wu, Ping; Deng, ChengXin; Chen, XiaoFang; Lu, ZeSheng; Weng, JianYu; Du, Xin 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
